Literature DB >> 4873454

Further evidence for a specific ganglioside fraction closely associated with myelin.

K Suzuki, J F Poduslo, S E Poduslo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4873454     DOI： 10.1016/0005-2760(68)90098-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  12 in total

1.  Drastically abnormal gluco- and galactosylceramide composition does not affect ganglioside metabolism in the brain of mice deficient in galactosylceramide synthase.

Authors:  K Suzuki; M T Vanier; T Coetzee; B Popko
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 2.  Biosynthesis of brain gangliosides.

Authors:  R Caputto; H J Maccioni; A Arce
Journal:  Mol Cell Biochem       Date:  1974-09-30       Impact factor: 3.396

3.  The identity of a myelin-like fraction isolated from developing brain.

Authors:  H C Agrawal; N L Banik; A H Bone; A N Davison; R F Mitchell; M Spohn
Journal:  Biochem J       Date:  1970-12       Impact factor: 3.857

4.  Study of myelin purity in relation to axonal contaminants.

Authors:  J E Haley; F G Samuels; R W Ledeen
Journal:  Cell Mol Neurobiol       Date:  1981-06       Impact factor: 5.046

5.  The specificity of anti-galactocerebroside antibody and its reaction with lysolecithin-solubilized myelin.

Authors:  N A Gregson; M Kennedy; S Leibowitz
Journal:  Immunology       Date:  1974-04       Impact factor: 7.397

6.  Heterosis for brain myelin content in mice.

Authors:  T N Seyfried; R K Yu
Journal:  Biochem Genet       Date:  1980-12       Impact factor: 1.890

7.  Locating lipids in the CNS: an historical perspective.

Authors:  B I Roots
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

8.  Genetic variability for regional brain gangliosides in five strains of young mice.

Authors:  T N Seyfried; G H Glaser; R K Yu
Journal:  Biochem Genet       Date:  1979-02       Impact factor: 1.890

9.  Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice.

Authors:  Laleh Saadat; Jeffrey L Dupree; John Kilkus; Xianlin Han; Maria Traka; Richard L Proia; Glyn Dawson; Brian Popko
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

10.  Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin.

Authors:  B Schwerer; H Lassmann; K Kitz; H Bernheimer
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.